Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide. [PDF]
Rassol N +7 more
europepmc +1 more source
Copper-mediated radiochemistry: historical impact, current trends, and future possibilities. [PDF]
Bowden GD +4 more
europepmc +1 more source
Advancing Internal Dosimetry in Personalized Nuclear Medicine: Toward Optimized Radiopharmaceutical Use in Clinical Practice. [PDF]
Alshehri AHD.
europepmc +1 more source
Picolinamide-functionalized macrocyclic chelators for <sup>203/212</sup>Pb theranostic radiotracers.
Osborne BE +10 more
europepmc +1 more source
Recommendations for Standardizing Nuclear Medicine Terminology and Data in the Era of Theranostics and Artificial Intelligence. [PDF]
Bradshaw TJ +12 more
europepmc +1 more source
Role of Radioiodine in Cancer Therapy: A Review of the Design and Challenges in Selecting Radioligands from Natural Sources. [PDF]
Fakih TM +6 more
europepmc +1 more source
The Impact of the COVID-19 Pandemic on a Nuclear Medicine Department in Riyadh, Saudi Arabia. [PDF]
Jambi LK +8 more
europepmc +1 more source
Next-Gen <sup>18</sup>F-Relay Reagent: Optimising [<sup>18</sup>F]Ethanesulfonyl Fluoride. [PDF]
Aulsebrook ML +7 more
europepmc +1 more source
Redox-driven speciation and colloid formation contribute the in vivo chemistry and organ deposition of Astatine-211. [PDF]
Dong X +11 more
europepmc +1 more source
Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors. [PDF]
Lilieholm C +19 more
europepmc +1 more source

